Decision hinge. SolarEdge must prove that its post-channel-destocking recovery can produce sustainable gross margin and adjusted operating profit without relying on one-time policy pull-forward, AMPTC timing, or a short-covering rerate.
Variant view. The obvious recovery story is now known: Q1 revenue grew YoY, non-GAAP margin held above 20%, free cash flow remained positive, and Q2 guidance points near breakeven. The less-owned question is whether a roughly 2.8x 2026e revenue valuation pays for too much before ex-credit margin quality and H2 demand are proven.
Action discipline. Keep SEDG on watchlist. Re-underwrite after Q2/Q3 evidence on Nexis sell-through, battery attach, AMPTC monetization, inventory turns, and non-GAAP operating profit. A formal target price is withheld because the evidence does not yet clear a completed ownership underwrite.
What The Market Is Missing
The company thesis and stock thesis have separated. SolarEdge has genuine operational recovery signals, but at the current price the stock needs the next two quarters to convert those signals into visible profit and cash durability.
Revenue recovery is no longer theoretical.
Q1 2026 revenue was $310.5m, up 41.5% YoY in the 10-Q and 46% YoY on the company's non-GAAP/earnings framing. Management said Q1 did not rely on major one-time safe-harbor or Section 25D pull-forward revenue. Q2 guidance of $325m-$355m implies sequential growth.
Sources: S1, S2.
Gross margin quality is the central diligence item.
Q1 GAAP gross margin was 22.0% and non-GAAP gross margin was 23.5%, but the 10-Q says AMPTC recognition was part of direct-cost improvement and the 10-K says excluding AMPTC incentives would have shifted gross margin into gross loss. That makes ex-credit manufacturing economics the gating proof.
Sources: S2, S3.
Nexis, storage, and AI power are call options, not the base case.
The CEO emphasized Nexis rollout and an AI data-center power roadmap. Those can change the multiple if customer traction appears, but the current underwrite should not capitalize them until backlog, design wins, or margin contribution become source-backed.
Source: S2.
Key Debates
1. Has channel destocking ended, or only paused?
Positive evidence: 2025 sales improved as U.S. and European channel inventory normalized, and Q1 2026 unit volumes were materially better in optimizers and batteries.
Disconfirming test: orders weaken after the 2025 policy rush, inventory rises again, or distributor receivables/credit allowances deteriorate.
2. Is profitability sustainable without incentives?
Positive evidence: Q2 guide at midpoint puts non-GAAP operating loss close to breakeven using $340m revenue, 25% non-GAAP gross margin, and $88.5m non-GAAP opex.
Disconfirming test: gross margin slips below low-20s when mix changes, U.S. manufacturing costs rise, AMPTC sales lag, or warranty costs re-accelerate.
3. Does the valuation leave room for error?
Positive evidence: if 2027 revenue reaches roughly $1.56b and adjusted EPS approaches $1.57, a durable recovery can support higher earnings-based value.
Disconfirming test: at the current price, SEDG already trades near 2.8x 2026e revenue including leases, while the consensus target from public estimate aggregation is $41.71.
4. Is short interest a feature or a risk?
Positive evidence: a high short base can amplify good news. MarketBeat reported 10.51m shares sold short, or 17.4% of float, as of May 15, 2026.
Disconfirming test: short-covering driven upside reverses when Q2/Q3 shows the recovery is slower than the price has started to discount.
Company Overview And Industry Position
SolarEdge develops and sells smart energy products across PV, storage and backup, EV charging, home energy management, grid services, and virtual power plants. The core heritage is DC-optimized inverter architecture: power optimizers, inverters, monitoring, and associated residential/commercial solar products.
Sales are worldwide through distributors, wholesalers, installers, and engineering/procurement/construction firms. That channel structure matters because the 2023-2024 demand shock was amplified by poor visibility into end-customer demand and distributor inventory.
Source: S3.
| Business signal | Current read | Implication |
|---|---|---|
| Q1 recognized volumes | 50.5k inverters, 2.4m optimizers, 331 MWh batteries | Battery attachment is the healthiest near-term product proof. |
| Nexis residential rollout | Units installed in key markets | Needs sell-through evidence, not just launch proof. |
| Commercial storage | CSS-OD 102.4 kWh and 197 kWh products expanded | Could diversify away from residential volatility if margins hold. |
| AI data-center power roadmap | Management-highlighted option | Not yet underwritable without customers/backlog/economics. |
Sector Context: The Macro Tailwind Is Real, But SEDG Is Not A Pure Solar Volume Bet
Global solar still grows.
The IEA's 2026 global review says renewable capacity additions reached 800 GW in 2025 and solar PV accounted for more than three-quarters of new renewable capacity, with solar additions above 600 GW for the first time.
Source: S8.
U.S. residential is the weak link.
SEIA/Wood Mackenzie reported U.S. 2025 solar installations fell 14% to 43.2 GWdc, while residential installed 4,647 MWdc, down 2%. SolarEdge's 10-K also flags H.R.1/OBBBA policy changes, Section 25D expiration, domestic-content requirements, and FEOC rules as demand and margin risks.
Sources: S7, S4.
Model Summary And Forecast Drivers
This is a minimum viable initiation model, not a rebuilt operating model. The key point is that consensus already assumes a rebound from 2025 revenue and near-break-even non-GAAP EPS in 2026, then a larger adjusted EPS step-up in 2027.
| Metric | FY2024 | FY2025 | Q1 2026 | 2026e / guide context | Evidence label |
|---|---|---|---|---|---|
| Revenue | $0.90b | $1.18b | $310.5m | $1.39b consensus; Q2 guide $325m-$355m | Fact / street estimate |
| Gross profit / margin | -$877.2m | $196.3m / 16.6% | $68.3m / 22.0% | Q2 non-GAAP GM guide 23%-27% | Fact / company outlook |
| Operating income / loss | -$1.41b | -$250m | -$55.0m | Consensus 2026 operating loss approx -$111m | Fact / street estimate |
| Net income / loss | -$1.81b | -$405.4m | -$57.4m | 2026 adjusted EPS consensus $0.03 | Fact / street estimate |
| Free cash flow | -$10m | $235m | $20.7m | 2026 consensus FCF approx $36m | Fact / street estimate |
Sources: S1, S2, S3, S6. EPS and forward PE on StockAnalysis are based on non-GAAP adjusted numbers.
Revenue driver
Consensus 2026 revenue of $1.39b implies about $370m per quarter in H2 after Q1 actuals and the Q2 guide midpoint. The setup therefore needs sequential H2 acceleration, not just stabilization.
Margin driver
The breakeven path is mostly gross margin plus opex discipline. Q2 midpoint math gives roughly $85m gross profit and $88.5m non-GAAP opex, leaving the company close to non-GAAP operating breakeven.
Earnings quality
GAAP EPS remains loss-making. Any P/E-based valuation should use adjusted EPS only after accepting exclusions for stock comp, restructuring, amortization, litigation/contingencies, and debt/accounting items.
Capitalization And Financing Gate
| Bridge item | Amount | Read |
|---|---|---|
| Basic shares outstanding | 60.8m | March 31, 2026 reported shares. |
| Unvested RSUs + PSUs | 5.2m | Potential dilution subject to vesting/performance. |
| 2029 convert principal | $337.0m | 2.25% notes due July 2029; conversion price approx $34.32. |
| Potential conversion shares | 9.8m | Capped calls offset dilution/cash above strike up to initial cap price of $48.84; current price is above that cap. |
| Cash + marketable + restricted cash | $582.6m | Includes restricted cash; company-reported cash/investment portfolio net of debt was $246.2m. |
| Recorded operating + finance lease liabilities | $57.6m | Included in this report's EV bridge; uncommenced lease commitments add additional fixed obligations. |
Why no formal target price?
SolarEdge is not overlevered, but the stock trades above the capped-call cap price, and the convert can create dilution or cash-settlement exposure depending on the company's election. The company also has purchase obligations and a large uncommenced lease commitment. A completed long-only underwrite should model fully diluted capitalization and after-financing cash returns before converting this into a target price.
Sources: S3, S5.
Valuation Map: Current Price Sits Above Base Recovery
The table below uses revenue-multiple reference math, not a formal target. It assumes $246.2m net cash, $57.6m lease liabilities, and 60.8m basic shares. Fully diluted convert mechanics could reduce upside per share above the capped-call cap.
| EV / revenue | Case read | $1.25b revenue | $1.39b revenue | $1.56b revenue | $1.70b revenue |
|---|---|---|---|---|---|
| 1.3x | Downturn multiple | $29.8 | $32.8 | $36.4 | $39.4 |
| 1.7x | Low recovery | $38.0 | $42.0 | $46.7 | $50.6 |
| 2.1x | Base recovery | $46.3 | $51.1 | $57.0 | $61.8 |
| 2.5x | Current-price band | $54.5 | $60.2 | $67.2 | $73.0 |
| 2.9x | Clean upside | $62.7 | $69.4 | $77.5 | $84.2 |
| 3.3x | Optionality case | $70.9 | $78.5 | $87.7 | $95.3 |
Downside mechanism: $30-$40
Revenue stalls near $1.25b-$1.30b, gross margin fails to hold after incentive/timing benefits, and the market reverts to a low recovery multiple. This is the credible capital-loss path.
Base recovery: $50-$60
Consensus 2026 revenue is achieved, margins hold in the mid-20s, and adjusted operating profit is within sight. At the current price, this case is not enough.
Upside case: $78-$95
H2 demand accelerates, Nexis/storage mix improves, 2027 adjusted EPS becomes credible, and the market pays a clean recovery multiple. This needs evidence beyond Q1.
Catalysts And Monitoring Queue
Risks And Falsifiers
Source Register, Conflicts, Assumptions
| ID | Source | Type / date | Use in report | Confidence |
|---|---|---|---|---|
| S1 | StockAnalysis SEDG quote/overview and internal market-data quote feed | Market data, checked Jun 8, 2026 | Quote cross-check, market cap, shares, valuation context, analyst summary. | Medium; intraday prices conflict by timestamp. |
| S2 | SolarEdge Q1 2026 earnings release | Company release, May 6, 2026 | Q1 revenue, margins, FCF, non-GAAP metrics, Q2 guidance, management commentary. | High for company-reported data; medium for management claims. |
| S3 | SolarEdge Form 10-Q for quarter ended March 31, 2026 | SEC filing, filed May 7, 2026 | Balance sheet, shares, convert, leases, product/company description, Q1 GAAP financials, liquidity. | High. |
| S4 | SolarEdge Form 10-K for FY2025 | SEC filing, filed Feb 25, 2026 | 2025/2024 financials, risk factors, H.R.1/OBBBA, AMPTC and FEOC commentary. | High. |
| S5 | 10-Q debt and equity-award notes | SEC filing, filed May 7, 2026 | 2029 convert conversion price, capped-call cap, potential dilution, RSU/PSU overhang. | High. |
| S6 | StockAnalysis SEDG forecast | Estimate aggregator, last updated Jun 2, 2026 | Consensus rating, price target, 2026/2027 revenue and adjusted EPS estimates. | Medium; public aggregation rather than direct terminal consensus. |
| S7 | SEIA/Wood Mackenzie Solar Market Insight 2025 year in review | Industry report, Mar 2026 | U.S. solar installation and residential solar context. | Medium-high. |
| S8 | IEA Global Energy Review 2026: Solar PV and wind | Industry report, 2026 | Global renewable and solar PV capacity context. | High for global industry context. |
| S9 | MarketBeat SEDG short interest | Market data, updated Jun 8, 2026 | Short interest and float positioning context. | Medium. |
| S10 | SolarEdge CFO appointment release | Company release, May 11, 2026 | Management transition watch item. | High for appointment fact. |
Unresolved conflicts
Intraday quote pages differed during report build ($65-$67 range). The report uses a $65.97 market-data quote for calculation and treats public quote pages as cross-checks. Refresh quote before trading or formal publication.
Major assumptions
Valuation map uses basic shares, company-reported net cash, and recorded lease liabilities. It does not fully model convert settlement elections, capped-call mark-to-market, or future award dilution.
Open evidence requests
Need direct consensus terminal export, segment/product gross margin, Nexis backlog/sell-through, AMPTC sale schedule, customer concentration, ownership/index membership, and a full diluted-cap table.
Evidence confidence: medium. Underwriting status: preliminary watchlist underwrite, not a completed buy recommendation. Recommended next handoff: equity-model-update for a full diluted-cap valuation model, then thesis-tracker for Q2/Q3 monitoring.